Abbott Sees Little Impact From Chinese Tenders
China’s Trade Battle With US Also Having No Effect On Company
Executive Summary
Competitive procurement practices for off-patent molecules in China are not affecting Abbott adversely because its local Established Pharmaceuticals portfolio is focused on niche, hard-to-make branded generics.